Kestra Advisory Services’s VanEck Pharmaceutical ETF PPH Stock Holding History

Kestra Advisory Services’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$389K	Sell	3,559 -1,314	-27%	-$136K	﹤0.01%	2541
2026 Q1	$506K	Buy	4,873 +2,724	+127%	+$290K	﹤0.01%	2211
2025 Q4	$222K	Buy	+2,149	New	+$209K	﹤0.01%	2800

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Kestra Advisory Services's PPH Position: Q2 2026 in Review

Kestra Advisory Services reduced its VanEck Pharmaceutical ETF (PPH) stake by 27% in Q2 2026, selling an estimated $136K and leaving 3,559 shares worth $389K. The position accounts for ﹤0.01% of the portfolio, ranked #2541.

Kestra Advisory Services first reported a position in PPH in Q4 2025 and has held it in 3 quarters since. The position peaked at $506K in Q1 2026. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Kestra Advisory Services held 3,559 shares of VanEck Pharmaceutical ETF worth $389K as of Q2 2026.
Kestra Advisory Services sold 1,314 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $136K.
VanEck Pharmaceutical ETF made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2541 holding.
Kestra Advisory Services first reported a position in VanEck Pharmaceutical ETF in Q4 2025 and has held it in 3 quarters since.
Kestra Advisory Services's VanEck Pharmaceutical ETF position peaked at $506K in Q1 2026.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.